Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-09-02

Clinical Trial Update: S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing S-1/Leucovorin against sLV5FU2 as first-line therapy for elderly patients with colorectal cancer; results are not provided in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Leucovorin (folinic acid)
  • S-1/Leucovorin (SL) (S-1; Leucovorin)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN